Interested in owning StemCellPatents.com? Contact info@stemcellpatents.com.
Patents (1436 Stem Cell Patents)

Erythropoietin-mediated neurogenesis

Patent Number: 6165783

Date of First Priority Issue: Friday October 24th, 1997
Date Issued: Tuesday December 26th, 2000
Assignee: Neuro Spheres Holdings Ltd. (Calgary, CA)
Inventors: Weiss, Samuel (Calgary, CA); Sorokan, S. Todd (Victoria, CA)

From Class: Differentiation
Comments: No comments

EPO is used clinically for treatment of anemia and is considered generally safe. This patent teaches that administration of EPO can stimulate the differentiation of neurons. Currently this concept is being tested (at least in part) by Stem Cell Therapeutics who are conducting clinical trials using EPO together with hCG for the treatment of stroke.

View this patent on the USPTO website.

Added to StemCellPatents.com on Monday October 16th, 2006

Social & Bookmarking:Digg 'Erythropoietin-mediated neurogenesis' Add 'Erythropoietin-mediated neurogenesis' to del.icio.us Add 'Erythropoietin-mediated neurogenesis' to Technorati Stumble 'Erythropoietin-mediated neurogenesis' Add 'Erythropoietin-mediated neurogenesis' to Furl Add 'Erythropoietin-mediated neurogenesis' to Reddit Add 'Erythropoietin-mediated neurogenesis' to Blinklist Add 'Erythropoietin-mediated neurogenesis' to Ma.gnolia Share 'Erythropoietin-mediated neurogenesis' on Facebook Add 'Erythropoietin-mediated neurogenesis' to Google Add 'Erythropoietin-mediated neurogenesis' to Yahoo Web 

Add Comment

You must be signed-in to add your comments.

Sign-in now or Join the StemCellPatents.com Community for free.



Home | News | Patents | Products | Jobs | Links | Search | Journal | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2020 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.10